GIGLI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 4.216
EU - Europa 3.132
AS - Asia 2.604
SA - Sud America 333
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 10.378
Nazione #
US - Stati Uniti d'America 4.130
SG - Singapore 981
IT - Italia 888
PL - Polonia 739
CN - Cina 582
DE - Germania 319
VN - Vietnam 272
BR - Brasile 254
HK - Hong Kong 212
SE - Svezia 190
NL - Olanda 169
FR - Francia 164
BD - Bangladesh 145
FI - Finlandia 144
GB - Regno Unito 138
KR - Corea 129
RU - Federazione Russa 79
IN - India 68
TR - Turchia 51
CA - Canada 49
IE - Irlanda 47
UA - Ucraina 47
BG - Bulgaria 44
MA - Marocco 34
AR - Argentina 32
CH - Svizzera 30
JP - Giappone 28
ES - Italia 27
MX - Messico 23
AT - Austria 21
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
IQ - Iraq 16
PK - Pakistan 16
RO - Romania 16
CO - Colombia 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
SA - Arabia Saudita 10
GR - Grecia 9
RS - Serbia 9
EC - Ecuador 8
KE - Kenya 8
LV - Lettonia 8
IL - Israele 7
TW - Taiwan 7
VE - Venezuela 7
JO - Giordania 6
EG - Egitto 5
KG - Kirghizistan 5
PH - Filippine 5
BO - Bolivia 4
DK - Danimarca 4
EU - Europa 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
IR - Iran 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
UG - Uganda 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KI - Kiribati 1
Totale 10.368
Città #
Warsaw 679
Singapore 608
Ashburn 573
Fairfield 309
Chandler 290
San Jose 259
Hong Kong 202
Woodbridge 175
Dallas 172
Beijing 156
Trieste 154
Houston 146
Munich 138
Ann Arbor 137
Seattle 135
Cambridge 127
Seoul 122
Hefei 109
Los Angeles 108
Chicago 104
Council Bluffs 104
Wilmington 104
Helsinki 95
Milan 78
Ho Chi Minh City 76
Boardman 75
London 69
Princeton 58
Lauterbourg 57
Rome 56
Hanoi 54
Jacksonville 51
Santa Clara 48
New York 46
Amsterdam 44
Dublin 42
Sofia 42
Zgierz 42
Columbus 38
Buffalo 35
Frankfurt am Main 35
Moscow 32
Izmir 30
Casablanca 26
Phoenix 25
Venice 25
Bremen 24
Grafing 24
São Paulo 24
Dearborn 23
Memphis 21
Orem 21
Palermo 21
Bern 20
Da Nang 20
Tokyo 20
Nuremberg 19
Denver 18
Lappeenranta 18
Redondo Beach 18
Düsseldorf 17
Brussels 16
The Dalles 16
Montreal 15
Naples 15
Salt Lake City 15
Chennai 14
Dong Ket 14
Jinan 14
Vienna 14
Atlanta 13
Toronto 13
Turin 13
Turku 13
Bologna 12
Brooklyn 12
Guangzhou 12
Udine 12
Des Moines 11
Elk Grove Village 11
Redwood City 11
Mestre 10
Poplar 10
San Diego 10
Belgrade 9
Boydton 9
Charlotte 9
Dhaka 9
Falls Church 9
Genoa 9
Haiphong 9
Nanjing 9
Pune 9
Wroclaw 9
Boston 8
City of London 8
Florence 8
Johannesburg 8
Kunming 8
Redmond 8
Totale 6.832
Nome #
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 508
Natural History of Dilated Cardiomyopathy in Children 434
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 401
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 358
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 328
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 324
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Chapter 13: Current Management and Treatment 276
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 273
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 264
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 256
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 255
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 255
Genetics of Dilated Cardiomyopathy: Clinical Implications 247
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 236
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 230
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 227
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 219
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 215
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 214
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 213
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 203
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 197
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 193
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 192
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 188
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 186
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 180
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 175
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 172
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 170
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 163
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation 160
Prognostic role of exercise intensity in familial Filamin C truncating variants 155
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 154
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 152
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 135
The Arrhythmic Phenotype in Cardiomyopathy 134
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 133
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 124
null 121
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 120
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 118
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 116
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials 110
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 106
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 92
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 91
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 73
The heart of dystrophinopathies 66
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 60
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 54
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves 36
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 35
What Should a Clinical Cardiologist Know About Cardiogenetics? 34
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 21
Totale 10.681
Categoria #
all - tutte 28.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/2022508 22 23 25 21 32 53 24 18 55 41 53 141
2022/2023825 67 116 95 120 68 117 7 77 79 11 48 20
2023/2024595 41 33 27 32 55 77 98 87 16 18 76 35
2024/20251.682 21 57 103 107 132 139 144 130 234 244 174 197
2025/20264.623 400 273 510 449 360 343 582 187 437 524 407 151
Totale 10.681